IndraLab

Statements


KCNQ1-V141M inhibits SQT2. 1 / 1
| 1

reach
"Inhibition of I Ks as a potential therapeutic strategy was further tested in another form of SQT2 caused by the KCNQ1 V141M mutation, which differs from the V307L mutation in that it induces a constitutively active voltage independent current component 11."